Background Immature platelets in the circulation can be measured as immature platelet fraction (IPF). Limited data exist regarding IPF during the course of an acute myocardial infarction (AMI), the association between IPF and extent of cardiac damage, and the long‐term prognostic implications of IPF in patients with AMI. Aims To examine the temporal course of IPF during the first month after AMI, the association between IPF and extent of cardiac damage, and the long‐term prognostic effect of IPF in AMI patients. Methods Patients with AMI treated with percutaneous coronary intervention (PCI) were examined. IPF was evaluated by a Sysmex XN‐3000 autoanalyzer, at 4 time points: baseline; one day post‐PCI; 3 days post‐PCI, and 30 days post‐PCI. The association between peak troponin‐T levels and IPF was evaluated. One‐year clinical outcomes (cardiac hospitalization, urgent revascularization, or death) were assessed. Results One hundred patients were included, mean age was 59.5 ± 11.3 years, 82 were men, 27 had diabetes, and 54 were hospitalized with ST‐segment elevation myocardial infarction (STEMI) and 46 with non‐ST segment elevation myocardial infarction (NSTEMI). The levels of IPF modestly decreased a day after PCI but did not change in subsequent measurements. Peak troponin‐T level was significantly associated with the levels of IPF at all 4 time points. IPF levels three days post‐PCI were associated with the composite clinical outcome at 1 year. Conclusions The levels of IPF following AMI remain relatively stable over a one‐month period. Higher levels of IPF during the acute phase of AMI appear to be associated with worse cardiac outcomes at 1 year.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.